ANAPTYSBIO, INC Net Income Loss

• ANAPTYSBIO, INC showed an increase of +90.9% in Net Income Loss from 2024 to 2025.
• This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2015 to 2025), ANAPTYSBIO, INC's Net Income Loss has declined by 144.8%.
• Historical annual values: Fiscal year 2025: -$13.23 million | Fiscal year 2024: -$145.23 million | Fiscal year 2023: -$163.62 million | Fiscal year 2022: -$128.72 million | Fiscal year 2021: -$57.80 million | Fiscal year 2020: -$19.93 million | Fiscal year 2019: -$97.34 million | Fiscal year 2018: -$61.66 million | Fiscal year 2017: -$30.07 million | Fiscal year 2016: -$4.26 million | Fiscal year 2015: -$5.41 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026